How to Afford CPAP + GLP-1 Polytherapy
What can sleep physicians do when obstructive sleep apnea patients can't afford every recommended therapy?
Tag: Eli Lilly
All
Latest
All
Latest
‘No Stone Unturned’: Scientists Map Benefits and Risks of GLP-1 Drugs
Scientists have systematically evaluated the benefits and risks of GLP-1 medications, such as Ozempic and Zepbound, among more than 2 million users.
All
Latest
FDA Approves Drug That Could Aid Weight Loss in Sleep Apnea Patients
The FDA approved a new weight management injection for adults with obesity or those who are overweight and have at least one weight-related medical condition, such as obstructive sleep apnea.
Digital Medicine Society Introduces Core Measures for Sleep Assessments
The core digital measures of sleep are designed to increase the availability of high-quality sleep assessments in a natural environment and improve research to advance overall population health.
Read More
Eli Lilly’s Weight Loss Drug Zepbound Cuts Sleep Apnea Severity in Late-Stage Studies
The drug was effective in lowering the apnea-hypopnea index in OSA patients with obesity who were and were not using positive airway pressure therapy over a 52-week treatment period.
Read More